pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

13,344 catalysts · 3,368 8k filing · 2,401 grant · 2,076 approval · 1,436 device 510k · 1,072 device recall · 1,000 device adverse event

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 19 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-10-29×clear all
type
  • 8k filing3,368
  • grant2,401
  • approval2,076
  • device 510k1,436
  • device recall1,072
  • device adverse event1,000
  • device pma950
  • earnings584
  • recall376
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Nov 10, 2025

    50
    ›Nov 13, 2025device recall278d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    InPen App, Model/CFN Number: MMT-8061 (Android Users) — Reason: When app is uninstalled and reinstalled, insulin pen software issue causes Choose Notification Style Screen to not show during setup so users can't choose to allow notifications to override phone settings when on mute/Do Not Disturb, and previously set up override permission is deleted, so audible and vibratory notifications not received, which may lead to delayed insulin therapy, hyperglycemia. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 13, 2025device recall278d agoMedline Industries, LP device recall (Cls II)

    SCISSORS, OR, SHARP/BLUNT, 5.5", STERILE, Item Number DYND04000 — Reason: The items may have weak packaging seals that may result in a breach of sterility if the seal fails and may lead to an increased risk of infection if product is utilized. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 13, 2025device recall278d agoMedline Industries, LP device recall (Cls II)

    FORCEP, STD STR, STERILE KELLY, 5.5 IN, Item Number DYNJ04048 — Reason: The items may have weak packaging seals that may result in a breach of sterility if the seal fails and may lead to an increased risk of infection if product is utilized. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025approval277d agoDANZITEN (NILOTINIB TARTRATE) — FDA approvalDANZITEN

    Sponsor: AZURITY. Form: TABLET. Route: ORAL

    full page →DANZITEN →fda approvals ↗
    ›Nov 14, 2025approval277d agoDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval(daratumumab + hyaluronidase (human recombinant))

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →(daratumumab + hyaluronidase (human recombinant)) →fda approvals ↗
    ›Nov 14, 2025approval277d agoALDACTAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Nov 14, 2025approval277d agoLUPRON DEPOT-PED KIT (LEUPROLIDE ACETATE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoDIAZEPAM — FDA approvalDIAZEPAM

    Sponsor: NAVINTA LLC. Form: GEL. Route: RECTAL

    full page →DIAZEPAM →fda approvals ↗
    ›Nov 14, 2025approval277d agoLENALIDOMIDE — FDA approvalLENALIDOMIDE

    Sponsor: ACCORD HLTHCARE. Form: CAPSULE. Route: ORAL

    full page →LENALIDOMIDE →fda approvals ↗
    ›Nov 14, 2025approval277d agoDIPHENHYDRAMINE HYDROCHLORIDE — FDA approvalPAI Holding Co LLC

    Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval277d agoFOSFOMYCIN TROMETHAMINE — FDA approvalFOSFOMYCIN TROMETHAMINE

    Sponsor: AUROBINDO PHARMA LTD. Form: FOR SOLUTION. Route: ORAL

    full page →FOSFOMYCIN TROMETHAMINE →fda approvals ↗
    ›Nov 14, 2025approval277d agoALDACTONE (SPIRONOLACTONE) — FDA approvalALDACTONE

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →ALDACTONE →fda approvals ↗
    ›Nov 14, 2025approval277d agoDILTIAZEM HYDROCHLORIDE — FDA approvalDILTIAZEM HYDROCHLORIDE

    Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

    full page →DILTIAZEM HYDROCHLORIDE →fda approvals ↗
    ›Nov 14, 2025approval277d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: ASCENT PHARMS INC. Form: TABLET. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Nov 14, 2025approval277d agoVORICONAZOLE — FDA approvalVORICONAZOLE

    Sponsor: HAINAN POLY PHARM. Form: SOLUTION. Route: INTRAVENOUS

    full page →VORICONAZOLE →fda approvals ↗
    ›Nov 14, 2025approval277d agoRIVAROXABAN — FDA approvalRIVAROXABAN

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →RIVAROXABAN →fda approvals ↗
    ›Nov 14, 2025approval277d agoTRUQAP (CAPIVASERTIB) — FDA approvalcapivasertib

    Sponsor: ASTRAZENECA. Form: TABLET. Route: ORAL

    full page →capivasertib →fda approvals ↗
    ›Nov 14, 2025device 510k277d agoPrinceton BioMeditech Corp. — Status™ COVID-19/Flu A&B (510k cleared)

    Product code: SCA. Advisory committee: Microbiology. Type: Dual Track

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoParagon Implant Mfg., LLC — Sterilization Trays (510k cleared)

    Product code: KCT. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoThis AG — System Sophi (510k cleared)

    Product code: HQC. Advisory committee: Ophthalmic. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoKLS-Martin L.P. — KLS Martin IPS Forearm System (510k cleared)

    Product code: HRS. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoFresenius Medical Care Renal Therapies Group, LLC — AquaC UNO H (510k cleared)Fresenius Medical Care AG

    Product code: FIP. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoOnward Medical, Inc. — ARC-EX System (510k cleared)Picard Medical, Inc.

    Product code: SDO. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoQingdao Future Medical Technology Co., Ltd. — Mesh Nebulizer (H6) (510k cleared)

    Product code: CAF. Advisory committee: Anesthesiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoEos Imaging — AutoDensity (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoBiomoneta Research Private Limited — Biomoneta Avata Rx (510k cleared)

    Product code: FRF. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoFusmobile, Inc. — Neurolyser XR (NXR100) (510k cleared)

    Product code: SGN. Advisory committee: Neurology. Type: Direct

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoPearl, Inc. — Second Opinion® Panoramic (510k cleared)

    Product code: MYN. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoInanovate, Inc. — Lyme-ID IgG Test; Bio-ID800 (510k cleared)

    Product code: LSR. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k277d agoAlovea Healthcare Co. , Ltd. — IPL Hair Removal Device (I6 S1, I6 D1, I6 M1) (510k cleared)NVP Healthcare Co Ltd

    Product code: OHT. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device pma277d agoAtriCure, Inc. — EPi-Sense ST Coagulation System (PMA supplement)AtriCure, Inc.

    Supplement type: Real-Time Process. Product code: OCM. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Nov 14, 2025device pma277d agoSTAAR Surgical Company — VISIAN ICL (IMPLANTABLE COLLAMER LENS) (PMA supplement)STAAR SURGICAL CO

    Supplement type: Normal 180 Day Track. Product code: MTA. Advisory committee: OP. Decision: APPR

    full page →fda device pma ↗
    ← prev
    page 16 of 267
    next →
    $AZN156.45-0.50%
    $PFE26.79-0.04%
    $FMS23.77+0.59%
    $PFE26.79-0.04%
    $AMRX18.34+1.05%
    $PMI0.1821-4.66%
    $ATRC
    $STAA26.18+3.36%